Form 4 for CLPT ClearPoint Neuro, Inc.
Accepted 2025-11-25 00:00:00 ET · period of report 2025-11-21 · accession 0001193125-25-297322 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-25 | 2025-11-21 | CLPT | D'Alessandro Danilo | CFO | M - OptEx | $8.10 | +3,555 | 69.9K | +5% | +$28.8K |
| D | 2025-11-25 | 2025-11-21 | CLPT | D'Alessandro Danilo | CFO | M - OptEx | $0.00 | -3,555 | 12.1K | -23% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-21 | M | A | 3,555 | $8.10 | 69,923 | D | — | — | (F1) Mr. D'Alessandro paid the exercise price for the option in cash and has held all shares received upon exercise. No shares of stock were sold in connection with this transaction. |
| 2 | Derivative | Stock Options (right to buy) | 2025-11-21 | M | D | 3,555 | $0.00 | 12,082 | D | $8.10 · — to 2033-03-06 | 3,555 Common Stock | (F1) Mr. D'Alessandro paid the exercise price for the option in cash and has held all shares received upon exercise. No shares of stock were sold in connection with this transaction. (F2) The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. The grant date is March 6, 2023. |